-

Viz.ai Launches AI-powered Viz™ Radiology Suite

Comprehensive solution tailored for radiologists to expedite patient diagnosis and treatment

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the introduction of an AI-powered radiology suite, specifically designed to alert the radiologist in their workflow of suspected diseases, prioritize worklists, and connect care teams in real-time. The Viz™ Radiology Suite integrates into the picture archiving and communication systems (PACS) of healthcare organizations to securely facilitate access to imaging data across departments and streamline patient diagnosis.

“With an increasing demand for imaging studies and a global shortage of radiologists, technologies that can be easily integrated into radiology workflows to enhance efficiency and streamline patient care are sorely needed,” said Allan Brook, M.D., FACR, FSIR, Director of Interventional Neuroradiology at Montefiore Medical Center and Professor of Radiology and Neurosurgery at Albert Einstein College of Medicine. “The Viz Radiology Suite offers radiologists important capabilities for optimizing imaging data and accelerating patient assessments with robust AI-powered features, such as real-time notifications, easy-to-use communication tools, and prioritized worklists.”

The Viz Radiology Suite provides a mobile and web image viewer with AI-powered notifications directly to the worklist, and integration with PACS, enabling efficient care coordination. Furthermore, Viz.ai provides a wide range of FDA-cleared algorithms across neurovascular, vascular, and cardiology diseases.

“We recognize the critical role that radiologists play within the healthcare ecosystem, and with this in mind, we continue to invest the necessary time and resources into understanding how we can best support them and the patients they serve,” said David Golan, PhD, chief technology officer and co-founder at Viz.ai. “As a result, we are excited to offer the Viz Radiology Suite, an AI-powered set of capabilities specifically designed for radiologists to advance patient care.”

About Viz.ai, Inc.

Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 200 million lives across 1,200+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz Platform is an intelligent care coordination solution that identifies more patients with a particular disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes. Backed by clinical data, the Viz Platform delivers significant value to patients, providers, and pharmaceutical and medical device companies. For more information visit viz.ai.

Contacts

Erich Sandoval
erich.sandoval@finnpartners.com
1-917-497-2867

More News From Viz.ai

Viz.ai Receives First and Only FDA 510(k) Clearance for Subdural Measurements

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Viz Subdural Plus, the first and only comprehensive solution for quantifying the size of collections like subdural hemorrhages (SDH) in the subdural space on non-contrast computed tomography (NCCT) images. The Viz Subdural Plus module is designed to support clinical-decision making by au...

New Study Demonstrates AI-Powered Care Coordination Reduces Transfer Time and Improves Outcomes in Intracerebral Hemorrhage Patients

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data showcasing the impact of Viz ICH and Viz ICH Plus in optimizing care for patients with intracerebral hemorrhage (ICH). The study, “Optimizing Intracerebral Hemorrhage Management and Interhospital Transfer With Viz ICH Plus AI Technology,” highlights how AI-powered detection and quantification significantly reduced interhospital transfer (IHT) ti...

Viz.ai Launches New Strategic Alliance to Accelerate Timely Diagnosis and Deliver AI-Powered Precision Care for Patients with Cancer

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new multi-year collaboration with Novartis aimed at transforming cancer care through the development of proprietary AI-powered workflows within the Viz Oncology Suite. This strategic alliance will focus on improving the identification and stratification of patients diagnosed with prostate and breast cancers based on key risk factors, accelerating...
Back to Newsroom